NEU Research

Professor George Jelinek is Head of the Neuroepidemiology Unit (NEU) within the Melbourne School of Population and Global Health at the University of Melbourne.

The NEU’s charter is to investigate the modifiable lifestyle risk factors that predict the progression of MS with a view to refining a preventive medicine approach to management of the disease.

New Research Shows Exercise Reduces Pain in MS

By OMS on November 23, 2018

Dr Jonathan White looks at the results from a systematic review on the effect of exercise on pain reduction in people with MS.

How easy or difficult is it to follow the OMS recommendations?

By OMS on October 31, 2018

Dr Claudia Marck and Emma Barnard from the Neuroepidemiology Unit (NEU) explain the results of their study and give seven practical tips to help you follow the program.

The view from OMS: three-year STOP-MS study results

By OMSWebEditor on June 7, 2018

Dr Jonathan White gives his view on the three-year follow up results of the STOP-MS study which aims to investigate whether people with MS who attend lifestyle retreats, show improvement in symptoms after adapting their lifestyles.

The lead researcher’s view: Are people living healthier three years after an OMS retreat?

By OMSWebEditor on June 7, 2018

A new research paper from the Neuroepidemiology Unit (NEU) at the University of Melbourne aimed to investigate whether people with MS who have attended a lifestyle retreat are leading healthier lives three years later.

Vote For George Jelinek & NEU Team In Battle Of The Labs!

By Admin on May 2, 2018

Professor George Jelinek and the team at the NEU are competing in this year’s ‘Battle of the Labs’, and they need your vote!

“Genuine Hope” – Experiences of partners of people with MS

By Admin on January 31, 2018

A new NEU research paper examines the role and experience of partners of people with MS.